Tier 3 — preclinical
Ingested nitrate and nitrite and stomach cancer risk: an updated review
Food and Chemical Toxicology
2012
50(10):3646-3665
Bibliography
- PubMed
- PMID 22889895
- Funding
- The American Meat Institute Foundation provided support to conduct this review.
- Competing interests
- N.S. Bryan and The University of Texas Health Science Center at Houston have financial interests in Neogenis, a company that develops, produces, and sells nitric-oxide-related products intended to improve health, develops diagnostics for nitric-oxide-related metabolites, and performs commercial measurement of nitric oxide metabolites in biological samples.
Study snapshot
| Design | Narrative literature review (not a primary study) |
|---|---|
| Model | N/A - review of animal toxicology and human epidemiological cohort literature on nitrate/nitrite intake and stomach cancer |
| Sample | N/A - review |
| Intervention | N/A - review of dietary/endogenous nitrate and nitrite exposure |
| Duration | N/A - review |
| Endpoints | Stomach/gastric cancer risk associated with dietary nitrate and nitrite intake; Carcinogenicity of nitrite in animal models with vs without co-administered nitrosamine precursors; Role of protein S-nitrosation vs N-nitrosation in NO cell signalling |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



